Breast cancer: metastatic.
Johnston
Stephen
S
The Royal Marsden NHS Trust, London, UK.
Stebbing
Justin
J
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001859:Bone Neoplasms / Q000556:secondary / Q000628:therapy; D001943:Breast Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy; D018714:Radiotherapy, Adjuvant; D013125:Spinal Neoplasms / Q000556:secondary / Q000628:therapy
D018931:Antineoplastic Agents, Hormonal